{"component": "definition", "props": {"groups": [{"snippet": "means (a) the Equity Value, divided by (b) the Fully Diluted Company Capitalization.", "size": 11, "snippet_links": [{"key": "equity-value", "type": "definition", "offset": [14, 26]}, {"key": "divided-by", "type": "clause", "offset": [28, 38]}, {"key": "fully-diluted-company-capitalization", "type": "definition", "offset": [47, 83]}], "samples": [{"hash": "7C7emkh4JEa", "uri": "/contracts/7C7emkh4JEa#equity-value-per-share", "label": "Business Combination Agreement (Atlantic Coastal Acquisition Corp. II)", "score": 34.9438743591, "published": true}, {"hash": "6GB3AfuVSfk", "uri": "/contracts/6GB3AfuVSfk#equity-value-per-share", "label": "Business Combination Agreement (Fortune Rise Acquisition Corp)", "score": 34.8097190857, "published": true}, {"hash": "l7obnSnmaPa", "uri": "/contracts/l7obnSnmaPa#equity-value-per-share", "label": "Business Combination Agreement (Phoenix Biotech Acquisition Corp.)", "score": 34.4236831665, "published": true}], "hash": "700454b69dbe7eed172cb0546bf78d17", "id": 1}, {"snippet": "means Adjusted EBITDA times the Multiplier, minus Total Debt plus Cash, divided by basic shares outstanding on the measurement date.", "size": 4, "snippet_links": [{"key": "adjusted-ebitda", "type": "definition", "offset": [6, 21]}, {"key": "total-debt", "type": "clause", "offset": [50, 60]}, {"key": "divided-by", "type": "clause", "offset": [72, 82]}, {"key": "shares-outstanding", "type": "definition", "offset": [89, 107]}, {"key": "measurement-date", "type": "definition", "offset": [115, 131]}], "samples": [{"hash": "e7DpzeKtfSE", "uri": "https://www.sec.gov/Archives/edgar/data/70415/000007041520000027/amendedltipjanuary2020.htm", "label": "Gp Strategies Corp", "score": 15.0396986008, "published": false}, {"hash": "xbS8M2Chpb", "uri": "https://www.sec.gov/Archives/edgar/data/70415/000007041518000106/exhibit1012018ltip.htm", "label": "Gp Strategies Corp", "score": 13.5804243088, "published": false}, {"hash": "dOpCqh0S5M2", "uri": "https://resources.gpstrategies.com/wp-content/uploads/2020/12/GPX-2018.06.30-10-Q-FINAL.pdf", "label": "resources.gpstrategies.com", "score": 8.7056808472, "published": false}], "hash": "24f7a99b667ad4242ec4a0d5bdf8e7a6", "id": 2}, {"snippet": "means an amount equal to (a) the Equity Value divided by (b) the number of Fully Diluted Company Equity Securities.", "size": 4, "snippet_links": [{"key": "equal-to", "type": "definition", "offset": [16, 24]}, {"key": "equity-value", "type": "definition", "offset": [33, 45]}, {"key": "divided-by", "type": "clause", "offset": [46, 56]}, {"key": "number-of", "type": "clause", "offset": [65, 74]}, {"key": "fully-diluted", "type": "definition", "offset": [75, 88]}, {"key": "company-equity-securities", "type": "definition", "offset": [89, 114]}], "samples": [{"hash": "aYSxSDlBKHr", "uri": "/contracts/aYSxSDlBKHr#equity-value-per-share", "label": "Business Combination Agreement (Vine Hill Capital Investment Corp.)", "score": 36.6851471595, "published": true}, {"hash": "Fs9RiKqMQ1", "uri": "/contracts/Fs9RiKqMQ1#equity-value-per-share", "label": "Business Combination Agreement (Moringa Acquisition Corp)", "score": 35.2532501221, "published": true}, {"hash": "c2zkbEmyeWh", "uri": "/contracts/c2zkbEmyeWh#equity-value-per-share", "label": "Business Combination Agreement (Moringa Acquisition Corp)", "score": 35.1519508362, "published": true}], "hash": "7bbc11373e0e8255705fc86515c46112", "id": 3}, {"snippet": "means (a) the Equity Value, divided by (b) the Fully-Diluted Company Capitalization. \u201cERISA\u201d means the Employee Retirement Income Security Act of 1974.", "size": 2, "snippet_links": [{"key": "equity-value", "type": "definition", "offset": [14, 26]}, {"key": "divided-by", "type": "clause", "offset": [28, 38]}, {"key": "company-capitalization", "type": "clause", "offset": [61, 83]}, {"key": "employee-retirement-income-security-act-of-1974", "type": "clause", "offset": [103, 150]}], "samples": [{"hash": "e9322D9Mqr5", "uri": "/contracts/e9322D9Mqr5#equity-value-per-share", "label": "Business Combination Agreement (Alterola Biotech Inc.)", "score": 33.6201248169, "published": true}, {"hash": "ibyv6rBtwH6", "uri": "http://pdf.secdatabase.com/2259/0001663577-24-000238.pdf", "label": "pdf.secdatabase.com", "score": 19.2825717926, "published": false}], "hash": "f8b9bd5e6a694b7e272f561db58782c7", "id": 4}, {"snippet": "means the result obtained by dividing the Equity Value by the number of fully-diluted shares of Common Stock outstanding immediately prior to the consummation of the Fundamental Transaction in which the Non-Public Entity was formed, resulted or survived.", "size": 2, "snippet_links": [{"key": "equity-value", "type": "definition", "offset": [42, 54]}, {"key": "number-of", "type": "clause", "offset": [62, 71]}, {"key": "shares-of-common-stock-outstanding", "type": "definition", "offset": [86, 120]}, {"key": "prior-to-the", "type": "clause", "offset": [133, 145]}, {"key": "consummation-of-the", "type": "clause", "offset": [146, 165]}, {"key": "fundamental-transaction", "type": "definition", "offset": [166, 189]}, {"key": "the-non", "type": "clause", "offset": [199, 206]}, {"key": "public-entity", "type": "clause", "offset": [207, 220]}], "samples": [{"hash": "liiY7Q2A9MY", "uri": "https://www.sec.gov/Archives/edgar/data/752902/000104746911006759/a2204895zex-4_24.htm", "label": "Lucid Inc", "score": 5.5797400475, "published": false}, {"hash": "kJYFyzre9us", "uri": "https://www.sec.gov/Archives/edgar/data/752902/000104746911003737/a2203377zex-4_14.htm", "label": "Lucid Inc", "score": 5.2840518951, "published": false}], "hash": "e740e0e36ac9d8d55bc251bed55d13f6", "id": 5}, {"snippet": "means an amount equal to quotient of (i) Common Equity Value DIVIDED by (ii) Fully Diluted Shares.", "size": 2, "snippet_links": [{"key": "equal-to", "type": "definition", "offset": [16, 24]}, {"key": "common-equity-value", "type": "definition", "offset": [41, 60]}, {"key": "divided-by", "type": "clause", "offset": [61, 71]}, {"key": "fully-diluted-shares", "type": "definition", "offset": [77, 97]}], "samples": [{"hash": "lswwIJyJePR", "uri": "https://www.sec.gov/Archives/edgar/data/1101019/000091205799009528/24.txt", "label": "Torque Acquisition Co LLC", "score": 2.0, "published": false}, {"hash": "2AQeuzLwnY9", "uri": "https://www.sec.gov/Archives/edgar/data/1100543/000091205799009684/1.txt", "label": "Gleason Reporting Group", "score": 2.0, "published": false}], "hash": "3d954cca50330ecb14b98ad144f22a2d", "id": 6}, {"snippet": "means the Equity Value divided by Deemed Shares Outstanding.", "size": 2, "snippet_links": [{"key": "equity-value", "type": "definition", "offset": [10, 22]}, {"key": "divided-by", "type": "clause", "offset": [23, 33]}, {"key": "deemed-shares-outstanding", "type": "definition", "offset": [34, 59]}], "samples": [{"hash": "9G4nhBag83Y", "uri": "https://www.sec.gov/Archives/edgar/data/1029557/000104746998013096/1.txt", "label": "Deferred Compensation Plan (Delta Beverage Group Inc)", "score": 6.0, "published": false}, {"hash": "1Q5lAEy2ssQ", "uri": "https://www.sec.gov/Archives/edgar/data/1029557/000091205797000160/8.txt", "label": "Delta Beverage Group Inc", "score": 2.0, "published": false}], "hash": "60ef947242a965c9e116fd972d69c5b7", "id": 7}, {"snippet": "set forth in Section 1.1 is hereby amended and restated in its entirety as follows:", "size": 1, "snippet_links": [{"key": "amended-and-restated", "type": "definition", "offset": [35, 55]}], "samples": [{"hash": "cxTC8YiUeOc", "uri": "/contracts/cxTC8YiUeOc#equity-value-per-share", "label": "Business Combination Agreement and Plan of Reorganization (Phoenix Biotech Acquisition Corp.)", "score": 35.0971946716, "published": true}], "hash": "c2434411d2d0baec48c2847e444e3515", "id": 8}, {"snippet": "means (a) the Equity Value, divided by (b) the aggregate number of shares of Company Common Stock outstanding as of immediately prior to the Effective Time, determined on an as-converted basis.", "size": 1, "snippet_links": [{"key": "equity-value", "type": "definition", "offset": [14, 26]}, {"key": "divided-by", "type": "clause", "offset": [28, 38]}, {"key": "common-stock-outstanding", "type": "clause", "offset": [85, 109]}, {"key": "prior-to-the-effective-time", "type": "clause", "offset": [128, 155]}, {"key": "converted-basis", "type": "definition", "offset": [177, 192]}], "samples": [{"hash": "cxTC8YiUeOc", "uri": "/contracts/cxTC8YiUeOc#equity-value-per-share", "label": "Business Combination Agreement and Plan of Reorganization (Phoenix Biotech Acquisition Corp.)", "score": 35.0971946716, "published": true}], "hash": "dabbee0a3a8eb989d02d2a44bcd339ec", "id": 9}, {"snippet": "means a good faith calculation of the consideration to be received per share of Common in the event of a Liquidation Event or Significant Transaction or, in the event of an Offering, the consideration to be received by the Corporation per share of Common in the Offering, provided that if a redemption is not in connection with such an event or no such value is otherwise reasonably determinable, then it shall mean the quotient of (i) the Equity Valuation (as defined below), divided by (ii) the Fully Diluted Capital Stock Number (as defined below), in each case as of the Convertible Common Redemption Date.", "size": 1, "snippet_links": [{"key": "good-faith", "type": "clause", "offset": [8, 18]}, {"key": "consideration-to-be-received", "type": "clause", "offset": [38, 66]}, {"key": "in-the-event-of-a", "type": "clause", "offset": [87, 104]}, {"key": "liquidation-event", "type": "clause", "offset": [105, 122]}, {"key": "significant-transaction", "type": "definition", "offset": [126, 149]}, {"key": "by-the-corporation", "type": "clause", "offset": [216, 234]}, {"key": "the-offering", "type": "definition", "offset": [258, 270]}, {"key": "provided-that", "type": "definition", "offset": [272, 285]}, {"key": "in-connection-with", "type": "clause", "offset": [309, 327]}, {"key": "an-event", "type": "clause", "offset": [333, 341]}, {"key": "equity-valuation", "type": "definition", "offset": [440, 456]}, {"key": "divided-by", "type": "clause", "offset": [477, 487]}, {"key": "stock-number", "type": "definition", "offset": [519, 531]}, {"key": "each-case", "type": "definition", "offset": [555, 564]}, {"key": "redemption-date", "type": "definition", "offset": [594, 609]}], "samples": [{"hash": "hR7PGzzxQGt", "uri": "/contracts/hR7PGzzxQGt#equity-value-per-share", "label": "Merger Agreement (AvidXchange Holdings, Inc.)", "score": 32.7097892761, "published": true}], "hash": "a474ee3339fc406358bdce29518406fb", "id": 10}], "next_curs": "CmMSXWoVc35sYXdpbnNpZGVyY29udHJhY3Rzcj8LEhpEZWZpbml0aW9uU25pcHBldEdyb3VwX3Y1NiIfZXF1aXR5LXZhbHVlLXBlci1zaGFyZSMwMDAwMDAwYQyiAQJlbhgAIAA=", "definition": {"title": "Equity Value Per Share", "snippet": "means (a) the Equity Value, divided by (b) the Fully Diluted Company Capitalization.", "size": 33, "id": "equity-value-per-share", "examples": ["For the avoidance of doubt, none of the equity awards or Holdco Ordinary Shares to be issued under the Incentive Equity Plan will result in any deduction to the Equity Value or the <strong>Equity Value Per Share</strong>."], "related": [["market-value-per-share", "Market Value per Share", "Market Value per Share"], ["net-asset-value-per-share", "Net Asset Value per Share", "Net Asset Value per Share"], ["book-value-per-share", "Book Value Per Share", "Book Value Per Share"], ["fair-market-value-per-share", "Fair Market Value Per Share", "Fair Market Value Per Share"], ["nav-per-share", "NAV per Share", "NAV per Share"]], "related_snippets": [], "updated": "2025-09-10T05:50:56+00:00"}, "json": true, "cursor": ""}}